Engineered Nanocatalysts Improve Cancer Therapy Clinical Safety

Although chemodynamic therapy (CDT)-triggered apoptosis is a potential anticancer treatment, its clinical translation is impeded due to the low efficacy and side effects. An article published in the journal Acta Biomaterialia, demonstrated the fabrication of surface-engineered ginsenoside Rg3-sheltered nanocatalysts with improved organ distribution, low toxicity, and increased in vivo efficacy. ​​​​​​​